NeuroBo Pharmaceuticals Inc. (NRBO) SEC News Jan. 05, 2026, 22:22 UTC (99% Neutral) METAVIA INC. (NRBO) Reports Q1 2026 Financial Results Full text
Register to leave comments News bot Jan. 5, 2026, 10:24 p.m. 📋 METAVIA INC. (NRBO) - Financial Results Filing Date: 2026-01-05 Accepted: 2026-01-05 17:22:53 Event Type: Financial Results Event Details: NeuroBo Pharmaceuticals Inc. (NRBO) Reports Q1 2026 Financial Results NeuroBo Pharmaceuticals Inc. (NRBO) announced its financial results for the period ending Q1 2026. Key Financial Highlights: Revenue: Not disclosed Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: $10 📊 Key Financial Metrics: Metric Value Cash $10 💼 Business Developments: No business developments data available. Structured Data: Company Name: NeuroBo Pharmaceuticals Inc.CIK: 0001638287Ticker Symbol: NRBOPeriod End Date: 2026-01-05Document Type: 8-K
📋 METAVIA INC. (NRBO) - Financial Results
Filing Date: 2026-01-05
Accepted: 2026-01-05 17:22:53
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics:
💼 Business Developments:
No business developments data available.
Structured Data: